Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

11 nov. 2013 07h05 HE | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Initial Results From the Folate Binding Protein Vaccine Phase 1 Trial at the Society for Immunotherapy of Cancer Conference

Folate Binding Protein (FBP) shown to be safe and immunogenic in its Phase 1 trial Phase 2a trial expected to initiate by year end PORTLAND, Ore., Nov. 11, 2013 (GLOBE NEWSWIRE) -- Galena...
06 nov. 2013 16h35 HE | Source: Galena Biopharma, Inc.

Galena Biopharma Reports Third Quarter 2013 Results

PORTLAND, Ore., Nov. 6, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company commercializing and developing innovative, targeted oncology treatments that address major...
07 oct. 2013 07h05 HE | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Oral Presentation at the American College of Surgeons Clinical Congress 2013

NeuVax induces a full immune response in treated patients and creates an immune memory to target residual cancer cells Phase 3 PRESENT HER2 1+/2+ patients confirmed as optimal treatment...
04 oct. 2013 07h05 HE | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the 12th Annual BIO Investor Forum

PORTLAND, Ore., Oct. 4, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major...
03 oct. 2013 07h05 HE | Source: Galena Biopharma, Inc.

Galena Biopharma Launches Abstral(R) (fentanyl) Sublingual Tablets for the Treatment of Breakthrough Cancer Pain

PORTLAND, Ore., Oct. 3, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major...
23 sept. 2013 15h22 HE | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Closing of Over-Allotment Option, Increasing Total Gross Proceeds to $40 Million

PORTLAND, Ore., Sept. 23, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that...
23 sept. 2013 07h05 HE | Source: Galena Biopharma, Inc.

Galena Biopharma to Present at the 20th Annual NewsMakers in the Biotech Industry Conference

PORTLAND, Ore., Sept. 23, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address...
18 sept. 2013 12h52 HE | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Closing of Public Offering of Common Stock and Warrants

PORTLAND, Ore., Sept. 18, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that...
13 sept. 2013 09h20 HE | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Pricing of Public Offering of Common Stock and Warrants

PORTLAND, Ore., Sept. 13, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (Nasdaq:GALE), a biopharmaceutical company focused on developing and commercializing innovative, targeted oncology treatments...
12 sept. 2013 16h05 HE | Source: Galena Biopharma, Inc.

Galena Biopharma Announces Proposed Public Offering of Common Stock and Warrants

PORTLAND, Ore., Sept. 12, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (Nasdaq:GALE), a biopharmaceutical company focused on developing and commercializing innovative, targeted oncology treatments...

Page précédente